SecBot SecBot
Institutional Cluster

DNLI

Denali Therapeutics Inc.
MIXED
Impact 4/10
Horizonweeks Processed5mo ago
Institutional cluster: 3 buyers, 4 sellers (mixed)
Actionable Insight ◆ Mixed

The institutional cluster is dominated by passive flows (buyers) vs. one sovereign exit and quant trims (sellers), producing a net reduction. Without a clear active-fund catalyst, the signal is weak. Monitor for a same-quarter SC 13D or earnings-driven catalyst to explain the Norges exit; until then, the cluster is a neutral-to-modestly-bearish data point on sentiment without strong trading conviction. Given prior model underperformance on DNLI reports, treat the impact as low confidence.

DirectionMixed
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$21.02
T+0 close · Jun 11, 2026 · via day close
Latest settled
+5.99%
T+60 · $22.28
Vs SPY
+1.60%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $21.02entry
  2. T+1 · 5mo ago +3.04%α +2.50% · $21.66
  3. T+5 · 5mo ago +11.75%α +11.32% · $23.49
  4. T+20 · 4mo ago +29.45%α +27.56% · $27.21
  5. T+60 · 2mo ago +5.99%α +1.60% · $22.28

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Mixed institutional activity in Denali Therapeutics for 2025-Q3: 3 large passive buyers (Morgan Stanley, UBS, BofA) added $27M in positions, led by UBS nearly doubling its stake to $29.2M, but 4 sellers, notably Norges Bank fully exiting a $55.2M position and T. Rowe Price trimming 30.6% of shares, removed ~$64.6M from the stock. The net selling pressure of ~$37.6M and the 100% exit by a sovereign wealth fund dominate the passive additions, but the cluster lacks conviction from active funds, muting the signal.

Key Financial Metrics

Direction
mixed
Buy Value
$67.7M
Net Flow
-$37.6M

Institutional Positions

Net institutional flow: -$37.6M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Morgan StanleyADD+28.8%$24.5M$6.2M
UBSDOUBLED+111.7%$29.2M$15.9M
BofAADD+47.8%$14.0M$4.9M

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
T. Rowe PriceTRIM-30.6%Not reported-$25.8K
Norges BankEXIT-100%$55.2M-$55.2M
CitadelTRIM-44.9%$17.5M-$7.5M
RenTechTRIM-69.4%$2.7M-$1.9M

Key Facts

  • 3 passive mega-funds added $27.0M in new holdings; UBS doubled to $29.2M (+111.7%)
  • 4 sellers reduced holdings by ~$64.6M; Norges Bank fully exited a $55.2M position
  • Net aggregate movement: sellers outweighed buyers by ~$37.6M
  • No active activist/event-driven fund participation, all buyers are passive; sellers include quant and sovereign

Financial Impact

3 institutional buyers added $27.0M (new total $67.7M), while 4 sellers reduced by $64.6M; net outflow ~$37.6M

institutional ownershipfloat allocation

Risk Factors

  • Norges Bank's 100% exit (sovereign account) signals institutional reluctance that may precede further unwinding by active managers
  • 45-day 13F lag means positions may already be reversed; UBS's doubling could be stale
  • Passive-only buying provides no evidence of active conviction; cluster has no activist or concentrated fund participation

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-DNLI-2025-Q3

Track record

17 reports on DNLI

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +23.19% at T+60 after the May 7, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.75 settles Nov 17
  2. Nov 3, 202613d ago 8-K Bullish 6/10 No price data
  3. Nov 3, 202613d ago Press Release Neutral 5/10 Entry $20.96 to $19.72 ▼ −5.92% −1.51% vs SPY
  4. Oct 30, 202617d ago Press Release Neutral 3/10 Entry $18.94 to $18.86 ▼ −0.42% +0.06% vs SPY
  5. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $18.66 No price data
  6. Sep 9, 20269w ago Insider Cluster Neutral 2/10 Entry $21.40 to $21.09 ▼ −1.45% −2.30% vs SPY
  7. Sep 4, 202610w ago Insider Cluster Neutral 2/10 Entry $22.08 to $21.57 ▼ −2.31% −1.84% vs SPY
  8. Aug 6, 202614w ago 8-K Mixed 6/10 Entry $24.83 to $25.00 ▲ +0.68% +0.71% vs SPY
  9. Jul 27, 202616w ago Press Release Neutral 1/10 Entry $24.05 No price data
  10. Jun 18, 202621w ago 8-K Bullish 6/10 Entry $23.31 to $24.05 ▲ +3.17% +3.49% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (10h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026